BiotechTube
Home/Lyra Therapeutics/David Davidson, M.D.
DD

David Davidson, M.D.

Chief Medical Officer

Lyra Therapeutics

Therapeutic Areas

Ear, Nose, and Throat (ENT)Inflammatory Diseases

Lyra Therapeutics Pipeline

DrugIndicationPhase
LYR-210Chronic Rhinosinusitis (CRS)Phase 3
LYR-220Chronic Rhinosinusitis (CRS)Not Specified (Pipeline)

Leadership Team at Lyra Therapeutics

MP
Maria Palasis, Ph.D.
President, Chief Executive Officer, and Director
CT
Catherine Turkel, CPA
Chief Financial Officer
RN
Richard Nieman, M.D.
Senior Vice President of Clinical Development
View full Lyra Therapeutics profile